INTERSECT ENT INC's ticker is XENT and the CUSIP is 46071F103. A total of 128 filers reported holding INTERSECT ENT INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2016 | $831,000 | -27.6% | 43,700 | -14.3% | 0.05% | -23.2% |
Q4 2015 | $1,147,000 | -31.2% | 51,000 | -28.4% | 0.07% | -28.9% |
Q3 2015 | $1,666,000 | -31.5% | 71,200 | -16.1% | 0.10% | -19.2% |
Q2 2015 | $2,431,000 | -37.0% | 84,900 | -43.1% | 0.12% | -18.9% |
Q1 2015 | $3,858,000 | – | 149,300 | – | 0.15% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
KOPP INVESTMENT ADVISORS LLC | 186,561 | $5,364,000 | 4.51% |
First Light Asset Management, LLC | 517,121 | $14,867,000 | 2.40% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,147,950 | $61,754,000 | 2.21% |
HealthCor Management, L.P. | 1,950,000 | $56,063,000 | 1.86% |
PURA VIDA INVESTMENTS, LLC | 200,000 | $5,750,000 | 1.21% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 112,000 | $2,469,000 | 1.17% |
Broadfin Capital, LLC | 234,200 | $6,733,000 | 0.99% |
Lombard Odier Asset Management (USA) Corp | 240,000 | $6,900,000 | 0.51% |
PURA VIDA INVESTMENTS, LLC | 83,527 | $2,401,000 | 0.50% |
Rock Springs Capital Management LP | 460,000 | $13,225,000 | 0.48% |